The Evaluation of Glypican-3 mRNA and Alpha-fetoprotein mRNA as biomarker for hepatocellular carcinoma in Dogs: A preliminary study

Glypican-3 (GPC-3) and alpha-fetoprotein (AFP) are considered powerful biomarkers for human hepatocellular carcinoma (HCC). The elevation of GPC-3 and AFP gene expression is commonly found in individual HCC patients. The detection of these biomarkers can be achieved with the examination of bloo...

Full description

Saved in:
Bibliographic Details
Main Authors: Aphinan Phosri, Kidsadagon Pringproa, Niyada Thitaram, Pinkarn Chantawong, Phongsakorn Chuammitri, Atigan= =Thongtharb
Format: Article
Language:English
Published: Faculty of Veterinary Medicine, Chiang Mai University 2024-10-01
Series:Veterinary Integrative Sciences
Online Access:https://he02.tci-thaijo.org/index.php/vis/article/view/271130
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850035926408888320
author Aphinan Phosri
Kidsadagon Pringproa
Niyada Thitaram
Pinkarn Chantawong
Phongsakorn Chuammitri
Atigan= =Thongtharb
author_facet Aphinan Phosri
Kidsadagon Pringproa
Niyada Thitaram
Pinkarn Chantawong
Phongsakorn Chuammitri
Atigan= =Thongtharb
author_sort Aphinan Phosri
collection DOAJ
description Glypican-3 (GPC-3) and alpha-fetoprotein (AFP) are considered powerful biomarkers for human hepatocellular carcinoma (HCC). The elevation of GPC-3 and AFP gene expression is commonly found in individual HCC patients. The detection of these biomarkers can be achieved with the examination of blood or tissue samples. Moreover, mRNA expressing GPC-3 and AFP are evaluated for detecting HCC in patients. In veterinary practice, data on GPC-3 and AFP of gene expression remain limited. Therefore, this study aims to evaluate the GPC-3 and AFP gene expression in dogs with HCC compared with other hepatic diseases. Twenty dogs were divided into two groups: HCC (n=6), and non-HCC (n=6). The liver tissue and plasma samples of each group were examined for GPC-3 and AFP gene expression by qPCR. The results showed a no statistical difference in the expression levels of GPC-3 gene in liver and plasma samples of dogs with HCC compared with non-HCC dogs. However, there was a positive correlation between the expression of GPC-3 gene and levels of aspartate transaminase (AST) in the HCC group (p-value = 0.002, R = 0.967). Moreover, the sensitivity, specificity, and accuracy of GPC-3 gene expression were higher than AFP gene expression in the HCC group. Therefore, this study conveys the expression of GPC-3 gene and AFP gene, suggesting a potential association with the development of HCC in dogs. The findings, particularly regarding the GPC-3 gene, could contribute to improved diagnostic methods in the future.
format Article
id doaj-art-6efec7109a4d4500a23d66cacdf9b1b3
institution DOAJ
issn 2629-9968
language English
publishDate 2024-10-01
publisher Faculty of Veterinary Medicine, Chiang Mai University
record_format Article
series Veterinary Integrative Sciences
spelling doaj-art-6efec7109a4d4500a23d66cacdf9b1b32025-08-20T02:57:21ZengFaculty of Veterinary Medicine, Chiang Mai UniversityVeterinary Integrative Sciences2629-99682024-10-0123310.12982/VIS.2025.076The Evaluation of Glypican-3 mRNA and Alpha-fetoprotein mRNA as biomarker for hepatocellular carcinoma in Dogs: A preliminary studyAphinan PhosriKidsadagon PringproaNiyada ThitaramPinkarn ChantawongPhongsakorn ChuammitriAtigan= =Thongtharb Glypican-3 (GPC-3) and alpha-fetoprotein (AFP) are considered powerful biomarkers for human hepatocellular carcinoma (HCC). The elevation of GPC-3 and AFP gene expression is commonly found in individual HCC patients. The detection of these biomarkers can be achieved with the examination of blood or tissue samples. Moreover, mRNA expressing GPC-3 and AFP are evaluated for detecting HCC in patients. In veterinary practice, data on GPC-3 and AFP of gene expression remain limited. Therefore, this study aims to evaluate the GPC-3 and AFP gene expression in dogs with HCC compared with other hepatic diseases. Twenty dogs were divided into two groups: HCC (n=6), and non-HCC (n=6). The liver tissue and plasma samples of each group were examined for GPC-3 and AFP gene expression by qPCR. The results showed a no statistical difference in the expression levels of GPC-3 gene in liver and plasma samples of dogs with HCC compared with non-HCC dogs. However, there was a positive correlation between the expression of GPC-3 gene and levels of aspartate transaminase (AST) in the HCC group (p-value = 0.002, R = 0.967). Moreover, the sensitivity, specificity, and accuracy of GPC-3 gene expression were higher than AFP gene expression in the HCC group. Therefore, this study conveys the expression of GPC-3 gene and AFP gene, suggesting a potential association with the development of HCC in dogs. The findings, particularly regarding the GPC-3 gene, could contribute to improved diagnostic methods in the future.https://he02.tci-thaijo.org/index.php/vis/article/view/271130
spellingShingle Aphinan Phosri
Kidsadagon Pringproa
Niyada Thitaram
Pinkarn Chantawong
Phongsakorn Chuammitri
Atigan= =Thongtharb
The Evaluation of Glypican-3 mRNA and Alpha-fetoprotein mRNA as biomarker for hepatocellular carcinoma in Dogs: A preliminary study
Veterinary Integrative Sciences
title The Evaluation of Glypican-3 mRNA and Alpha-fetoprotein mRNA as biomarker for hepatocellular carcinoma in Dogs: A preliminary study
title_full The Evaluation of Glypican-3 mRNA and Alpha-fetoprotein mRNA as biomarker for hepatocellular carcinoma in Dogs: A preliminary study
title_fullStr The Evaluation of Glypican-3 mRNA and Alpha-fetoprotein mRNA as biomarker for hepatocellular carcinoma in Dogs: A preliminary study
title_full_unstemmed The Evaluation of Glypican-3 mRNA and Alpha-fetoprotein mRNA as biomarker for hepatocellular carcinoma in Dogs: A preliminary study
title_short The Evaluation of Glypican-3 mRNA and Alpha-fetoprotein mRNA as biomarker for hepatocellular carcinoma in Dogs: A preliminary study
title_sort evaluation of glypican 3 mrna and alpha fetoprotein mrna as biomarker for hepatocellular carcinoma in dogs a preliminary study
url https://he02.tci-thaijo.org/index.php/vis/article/view/271130
work_keys_str_mv AT aphinanphosri theevaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT kidsadagonpringproa theevaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT niyadathitaram theevaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT pinkarnchantawong theevaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT phongsakornchuammitri theevaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT atiganthongtharb theevaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT aphinanphosri evaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT kidsadagonpringproa evaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT niyadathitaram evaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT pinkarnchantawong evaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT phongsakornchuammitri evaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy
AT atiganthongtharb evaluationofglypican3mrnaandalphafetoproteinmrnaasbiomarkerforhepatocellularcarcinomaindogsapreliminarystudy